Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial
- Resource Type
- Article
- Source
- In
The Lancet Neurology September 2020 19(9):727-737 - Subject
Primary Research Articles - Language
- ISSN
- 1474-4422